What is NDC 72865-321?

72865-321 is the product NDC for Rivaroxaban, Rivaroxaban 2.5 mg/1 tablet, film coated, listed with the FDA by XLCare Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

XLCare Pharmaceuticals, Inc., NDC labeler code 72865. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rivaroxaban?

32 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rivaroxaban NDC 72865-321 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72865-321Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72865-0321Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72865-321-18	7286503211872865032118	180 TABLET, FILM COATED in 1 BOTTLE (72865-321-18)Marketed from Dec 17, 2025
72865-321-60	7286503216072865032160	60 TABLET, FILM COATED in 1 BOTTLE (72865-321-60)Marketed from Dec 17, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rivaroxaban
Generic name (nonproprietary): rivaroxaban
Active ingredients: Rivaroxaban — 2.5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: XLCare Pharmaceuticals, Inc.NDC labeler code 72865
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219332
Marketing start: Dec 17, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Factor Xa Inhibitors (Mechanism)
Identifiers: Product ID 72865-321_a24524f3-072e-4484-b6c8-77c70e4e3005SPL ID a24524f3-072e-4484-b6c8-77c70e4e3005SPL set ID 291011aa-60eb-4109-b59c-1c521fbeac4fRxCUI 2059015UNII 9NDF7JZ4M3UPC 0372865321188, 0372865321607
Pharmacologic class: Factor Xa Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472865032118 followed by a unit qualifier and the quantity

Package 72865-0321-18. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 17, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Rivaroxaban tablets are a factor Xa inhibitor indicated: to reduce the risk of major cardiovascular events in patients with coronary artery disease (CAD) (1.7) to reduce the risk of major thrombotic vascular events in patients with peripheral artery disease (PAD), including patients after recent lower extremity revascularization due to symptomatic PAD (1.8) 1.7 Reduction of Risk of Major Cardiovascular Events in Patients with Coronary Artery Disease (CAD) Rivaroxaban tablets, in combination with aspirin, is indicated to reduce the risk of major cardiovascular events (cardiovascular death, myocardial infarction, and stroke) in adult patients with coronary artery disease. 1.8 Reduction of Risk…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72865-321

What is NDC 72865-321?: 72865-321 is the product NDC for Rivaroxaban, Rivaroxaban 2.5 mg/1 tablet, film coated, listed with the FDA by XLCare Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rivaroxaban.
What is the active ingredient?: Rivaroxaban.
Who is the labeler?: XLCare Pharmaceuticals, Inc., NDC labeler code 72865. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rivaroxaban?: 32 other product NDCs are listed under this name. See all Rivaroxaban NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rivaroxaban NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rivaroxaban	Rivaroxaban 2.5 mg/1	TabletOral	Lifestar Pharma LLC	70756-006	70756-0006-1270756-0006-6070756-0006-81+1 more
Rivaroxaban	Rivaroxaban 2.5 mg/1	TabletOral	Micro Labs Limited	42571-345	42571-0345-0542571-0345-3042571-0345-60
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-890	72603-0890-0172603-0890-02
rivaroxaban	Rivaroxaban 10 mg/1	Tablet, Film coatedOral	Changzhou Pharmaceutical Factory	55488-0540	55488-0540-01
rivaroxaban	Rivaroxaban 15 mg/1	Tablet, Film coatedOral	Changzhou Pharmaceutical Factory	55488-0541	55488-0541-01
rivaroxaban	Rivaroxaban 20 mg/1	Tablet, Film coatedOral	Changzhou Pharmaceutical Factory	55488-0542	55488-0542-01
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-416	72205-0416-0272205-0416-0372205-0416-04+1 more
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, CoatedOral	Sun Pharmaceutical Industries, Inc.	51672-4228	51672-4228-0451672-4228-09
rivaroxaban	Rivaroxaban 2.5 mg/1	TabletOral	Florida Pharmaceutical Products, LLC	71921-405	71921-0405-0671921-0405-21
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	Indoco Remedies Limited	14445-147	14445-0147-1014445-0147-1814445-0147-60

All 33 Rivaroxaban NDCs

Other NDCs under ANDA 219332

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219332
Product	Strength	Form · route	Labeler	Product NDC
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-496